The Category
The cosmetics industry has spent considerable time treating the skin.
It has been somewhat less attentive to the brain.
Stress is doing something rather specific to your customers complexions. Through the HPA axis, chronic stress elevates cortisol. Elevated cortisol degrades collagen, impairs the skin barrier, triggers inflammation, and accelerates every visible sign of ageing. Formula in the market presumably addresses the skin. The question worth considering is whether it addresses this.
THE SKIN-BRAIN AXIS
Brain and skin share an embryonic origin and a rather productive ongoing relationship. What distresses one rather reliably distresses the other. Psychodermatology has established this. The cosmetics industry is catching up.
THE DEMAND
Your customers are stressed. Chronically. Measurably. Visibly. They are spending on skincare that addresses the surface of the problem. The more interesting opportunity, and the one category has not yet fully addressed, is the source.
THE CATEGORY
Neurocosmetics is the recognition that effective skincare must address the biological mechanism driving skin ageing, not only its consequences. KSM-66 Ashwagandha COS is among the first ingredients to support this purpose. The category has, at last, something to stand on.
CLINICAL FOUNDATIONS
50+
PEER-REVIEWED HUMAN RCTS
27.9%
CORTISOL REDUCTION, DB-RCT
3,000
YEARS DOCUMENTED TRADITIONAL USE
How stress reaches the skin
The Neurocosmetics Category · The Skin-Brain Axis
Four steps. One pathway.
STRESS
The brain perceives it. The cascade begins
HPA AXIS
A rather efficient pathway. Unfortunately
CORTISOL
The mechanism. Not merely the symptom
SKIN DAMAGE
The part the industry currently addresses
WHAT THIS MEANS
Every consequence your formula is designed to address (dullness, loss of firmness, impaired barrier, accelerated wrinkling) originates here. At the brain. Not at the skin. An ingredient that reduces cortisol by 27.9% and skin stress by 15.2% in clinical trials addresses all of these simultaneously. Rather more efficient than addressing each in turn.
WHAT IT ADDS TO TOPICAL FORMULATION
Neurocosmetics is not a competitor to topical skincare. It is a rather useful addition to it. A serum addressing hydration while cortisol continues to degrade the barrier is working harder than it needs to. Add an ingredient that addresses the source, and your topical simply has to perform.
THE FORMULATOR'S OPPORTUNITY
Neurocosmetics is the category that makes neuroscience a formulation requirement, not a marketing afterthought. That raises the barrier to entry considerably. It also raises the value of being there first.
TOPICAL AND ORAL. BOTH VALIDATED
KSM-66 Ashwagandha COS is validated in both topical and oral applications. The same ingredient. Two delivery formats, each proven to reduce cortisol and deliver measurable skin and hair benefits.
Address the source. The skin, it turns out, is rather good at the rest.
